Senior Manager, Drug Safety

Salary Range: $165,067.00 To $204,228.00 Annually About BlossomHill Therapeutics: BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small molecule medicines which address significant unmet medical needs in cancer treatment. Founded and led by industry veteran J. Jean Cui, Ph.D., with her proven track record in oncology drug design and development - including three FDA-approved drugs - BlossomHill applies cutting-edge science to address key oncogenic drivers and improve patient outcomes in difficult-to-treat cancers. The company’s lead clinical programs include BH-30643, a first-in-class, macrocyclic, non-covalent, mutant-selective OMNI-EGFRTM inhibitor for the treatment of EGFR-mutated non-small cell lung cancer, BH-30236, a macrocyclic CLK inhibitor for the treatment of relapsed or refractory acute myeloid leukemia or higher-risk myelodysplastic syndrome and BH-501284, a non-covalent, pan-KRAS inhibitor for treatment of diverse KRAS-mutant tumors. The Senior Manager, Drug Safety will play a key role in supporting the company’s drug safety and pharmacovigilance activities. This hands-on role will provide clinical, scientific, and operational expertise in the identification, assessment, documentation, and management of safety information arising from clinical trials. The successful candidate will have progressive, hands-on drug safety/pharmacovigilance experience and a strong understanding of clinical safety principles, global regulatory requirements, safety surveillance, and outsourced pharmacovigilance operations. The role will collaborate closely with Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Data Management, and other cross-functional teams to ensure timely, compliant, and high-quality safety assessment and reporting. The ideal candidate will bring a clinical background, with a nursing degree preferred, combined with hands-on experience in drug safety and the ability to work effectively in a dynamic, development-stage oncology environment. This is an onsite role based in our San Diego office. Key Responsibilities Support and provide clinical expertise across drug safety and pharmacovigilance activities for oncology clinical development programs. Manage end-to-end SAE operations, including CRO management for case intake, triage, case review, follow-up, regulatory reporting, clinical database reconciliation, escalation, and closure of safety information. Oversee case processing activities, including MedDRA coding, narrative development, quality control, medical review workflow, case distribution, and compliance with applicable reporting timelines and procedures. Contribute to the submission of expedited safety reports, DSURs and other aggregate reports, and related pharmacovigilance deliverables. Support clinical trial safety activities, including review of aggregate safety data, safety listings, relevant safety analyses, and clinical trial safety documentation. Collaborate with Clinical Development and Clinical Operations on safety-related aspects of clinical trials, including SAE review, safety data reconciliation, and ongoing benefit-risk assessment. Contribute to the development and maintenance of safety-related processes, procedures, work instructions, and safety management plans. Support safety input into clinical study protocols, informed consent documents, investigator materials, and other clinical development documents as appropriate. Participate in cross-functional safety review meetings and communicate clinically relevant safety findings and recommendations to internal stakeholders. Provide day-to-day oversight of external pharmacovigilance vendors/CROs, including work allocation, case quality and timeliness, reconciliations, issue escalation, performance metrics, and compliance with safety data exchange agreements and company procedures. Ensure drug safety activities are conducted in accordance with applicable company procedures, ICH guidelines, FDA regulations, and global pharmacovigilance requirements. Support inspection readiness and contribute to responses to regulatory inquiries related to drug safety and pharmacovigilance. Assist with the preparation and review of safety-related documentation for regulatory submissions. Contribute to continuous improvement of pharmacovigilance processes, systems, and quality practices as the company and its oncology portfolio evolve. Qualifications Bachelor's degree in Nursing preferred. Minimum of 6 years of progressively responsible experience in drug safety/pharmacovigilance within the pharmaceutical, biotechnology, or CRO environment, including substantial hands-on clinical-trial safety operations experience. Required experience includes: End-to-end ICSR processing and medical/clinical review, including seriousness, expectedness, causality, MedDRA coding, narrative review, follow-up, quality control, and case closure SAE management for interventional clinical trials, including clinical database-to-safety database reconciliation and resolution of data discrepancies Preparation and review of expedited reports and aggregate safety deliverables, including DSURs; experience supporting safety sections of investigator brochures and regulatory submissions is preferred Direct oversight of pharmacovigilance vendors/CROs, including case quality, timeliness, KPIs, issue management, reconciliations, and inspection-ready documentation Use of a validated global safety database, preferably Oracle Argus, and familiarity with EDC systems and safety data transfer/reconciliation processes Development or implementation of pharmacovigilance SOPs, work instructions, safety management plans, and safety data exchange agreements Ongoing safety surveillance, review of aggregate safety data and listings, signal identification, and communication of clinically meaningful findings to cross-functional stakeholders Working knowledge of ICH and FDA safety/pharmacovigilance regulations and guidelines; familiarity with global regulatory requirements is a plus. Knowledge of MedDRA coding and terminology. Demonstrated proficiency with pharmacovigilance/safety databases, preferably Oracle Argus; experience with EDC systems and safety reporting tools is highly desirable. Strong clinical judgment and the ability to evaluate complex safety information and communicate its significance clearly. Excellent written and verbal communication skills, with the ability to collaborate effectively across multidisciplinary teams. Strong attention to detail, organizational skills, and ability to manage multiple priorities and deliverables in a deadline-driven environment. Ability to work independently while also contributing effectively within a collaborative, cross-functional team. At least 2 years of oncology drug-safety or oncology clinical-development experience is strongly preferred, particularly in early-phase clinical trials. Experience working in a biotechnology or emerging pharmaceutical company environment is a plus. The company provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state, or local laws. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training. Recruiters and Agencies: BlossomHill Therapeutics does not accept unsolicited referrals or resumes from any source other than directly from candidates. We will not consider unsolicited referrals and/or resumes from vendors including and without limitation, search firms, staffing agencies, fee-based referral services and recruiting agencies. The submission of referrals or resumes by anyone other than a candidate directly to BlossomHill employees is strictly prohibited. Unsolicited referrals and resumes sent to BlossomHill Therapeutics are deemed gratuitous, and the company will not be obligated or bound in any way to pay any referral or other fee if a person referred to us from a source other than a candidate is hired. E-Verify: BlossomHill Therapeutics participates in E-Verify and will provide the federal government with your Form I-9 information to confirm that you are authorized to work in the U.S. If E-Verify cannot confirm that you are authorized to work, this employer is required to give you written instructions and an opportunity to contact the Department of Homeland Security (DHS) or Social Security Administration (SSA) to resolve the is sue. #J-18808-Ljbffr BlossomHill Therapeutics, Inc.